Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Pediatrics|November 1, 1991
Severe neonatal protein C deficiency: prevalence and thrombotic riskM J Manco-Johnson, T C Abshire, L J Jacobson, et al.
Blood|August 29, 2000
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group StudyT C Abshire, B H Pollock, A L Billett, et al.
Hemoglobin|January 1, 1992
Molecular genetic studies in black families with sickle cell anemia and unusually high levels of fetal hemoglobinW K Seltzer, T C Abshire, P A Lane, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 13, 2000
Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patientsA L Dunn, J R Powers, M J Ribeiro, et al.
The Journal of Pediatrics|July 1, 1992
Relative value of diagnostic studies for von Willebrand diseaseE J Werner, T C Abshire, D S Giroux, et al.
Cancer|August 15, 1990
The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?T C Abshire, S H Gold, L F Odom, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 8, 2018
Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis NetworkE Holm, K Steen Carlsson, S Lövdahl, et al.
The Journal of Pediatrics|December 1, 1993
Prevalence of von Willebrand disease in children: a multiethnic studyE J Werner, E H Broxson, E L Tucker, et al.
Leukemia|January 19, 2000
Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemiaM Zhou, L Gu, T C Abshire, et al.
Thrombosis and Haemostasis|July 15, 2000
Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study GroupT C Abshire, H H Brackmann, I Scharrer, et al.
Pageof 3